CRYSTAL MEAD: Open Payments
NPI 1497861306 · EDGEWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 50 payments from 16 companies in 2025. Trend: 2023 $405 · 2024 $839 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $195 |
| Novo Nordisk Inc | 10 | $169 |
| Tandem Diabetes Care, Inc. | 3 | $71 |
| BETA BIONICS, INC. | 3 | $69 |
| ABBVIE INC. | 4 | $65 |
| Insulet Corporation | 4 | $62 |
| Dexcom, Inc. | 2 | $54 |
| Amgen Inc. | 2 | $47 |
| Corcept Therapeutics | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
Products named: FREESTYLE LIBRE 3, Wegovy, t:slim X2 Insulin Pump with Control-IQ, iLet Bionic Pancreas, UBRELVY, Omnipod, Dexcom G6 Transmitter, Rybelsus.
Industry payments across FL — which companies pay providers there.
